These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Diagnostic and Prognostic Value of Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) in Focal Segmental Glomerulosclerosis and Impact of Detection Method. Winnicki W; Sunder-Plassmann G; Sengölge G; Handisurya A; Herkner H; Kornauth C; Bielesz B; Wagner L; Kikić Ž; Pajenda S; Reiter T; Schairer B; Schmidt A Sci Rep; 2019 Sep; 9(1):13783. PubMed ID: 31551522 [TBL] [Abstract][Full Text] [Related]
6. Circulating Permeability Factors in Primary Focal Segmental Glomerulosclerosis: A Review of Proposed Candidates. Königshausen E; Sellin L Biomed Res Int; 2016; 2016():3765608. PubMed ID: 27200372 [TBL] [Abstract][Full Text] [Related]
7. Pre-transplant angiotensin receptor II type 1 antibodies and risk of post-transplant focal segmental glomerulosclerosis recurrence. Mujtaba MA; Sharfuddin AA; Book BL; Goggins WC; Khalil AA; Mishler DP; Fridell JA; Yaqub MS; Taber TE Clin Transplant; 2015 Jul; 29(7):606-11. PubMed ID: 25973696 [TBL] [Abstract][Full Text] [Related]
8. Decreased glomerular filtration as the primary factor of elevated circulating suPAR levels in focal segmental glomerulosclerosis. Harita Y; Ishizuka K; Tanego A; Sugawara N; Chikamoto H; Akioka Y; Tsurumi H; Miura K; Gotoh Y; Tsujita M; Yamamoto T; Horike K; Takeda A; Oka A; Igarashi T; Hattori M Pediatr Nephrol; 2014 Sep; 29(9):1553-60. PubMed ID: 24705794 [TBL] [Abstract][Full Text] [Related]
9. Perturbations in podocyte transcriptome and biological pathways induced by FSGS associated circulating factors. Rashmi P; Sigdel TK; Rychkov D; Damm I; Da Silva AA; Vincenti F; Lourenco AL; Craik CS; Reiser J; Sarwal MM Ann Transl Med; 2023 Jun; 11(9):315. PubMed ID: 37404982 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of Rituximab in Treatment-Resistant Focal Segmental Glomerulosclerosis With Elevated Soluble Urokinase-Type Plasminogen Activator Receptor and Activation of Podocyte β3 Integrin. Hladunewich MA; Cattran D; Sethi SM; Hayek SS; Li J; Wei C; Mullin SI; Reich HN; Reiser J; Fervenza FC Kidney Int Rep; 2022 Jan; 7(1):68-77. PubMed ID: 35005315 [TBL] [Abstract][Full Text] [Related]
11. Permeability factors in focal and segmental glomerulosclerosis. Reiser J; Nast CC; Alachkar N Adv Chronic Kidney Dis; 2014 Sep; 21(5):417-21. PubMed ID: 25168830 [TBL] [Abstract][Full Text] [Related]
12. Primary and Recurrent Focal Segmental Glomerulosclerosis Closely Link to Serum Soluble Urokinase-type Plasminogen Activator Receptor Levels. Jin J; Li YW; He Q Transplant Proc; 2015; 47(6):1760-5. PubMed ID: 26293047 [TBL] [Abstract][Full Text] [Related]
13. [Value of soluble urokinase receptor serum levels in the differential diagnosis between idiopathic and secondary focal segmental glomerulosclerosis]. Segarra A; Jatem E; Quiles MT; Arbós MA; Ostos H; Valtierra N; Carnicer C; Salcedo MT Nefrologia; 2014; 34(1):53-61. PubMed ID: 24463863 [TBL] [Abstract][Full Text] [Related]
14. Identifying a potential biomarker for primary focal segmental glomerulosclerosis and its association with recurrence after transplantation. Harel E; Shoji J; Abraham V; Miller L; Laszik Z; Thurison T; King A; Olshen A; Leung J; Szabo G; Hann B; Høyer-Hansen G; Craik CS; Vincenti F Clin Transplant; 2019 Mar; 33(3):e13487. PubMed ID: 30689221 [TBL] [Abstract][Full Text] [Related]